Protagenic Therapeutics Stock Filter Stocks by Fundamentals

PTIX Stock  USD 0.50  0.02  3.85%   
Protagenic Therapeutics fundamentals help investors to digest information that contributes to Protagenic Therapeutics' financial success or failures. It also enables traders to predict the movement of Protagenic Stock. The fundamental analysis module provides a way to measure Protagenic Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Protagenic Therapeutics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Protagenic Therapeutics Institutional Holders

Institutional Holdings refers to the ownership stake in Protagenic Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Protagenic Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Protagenic Therapeutics' value.
Shares
Wells Fargo & Co2024-06-30
0.0
Eagle Asset Management, Inc.2024-06-30
0.0
Citadel Advisors Llc2024-09-30
40.9 K
Vanguard Group Inc2024-09-30
33.2 K
Geode Capital Management, Llc2024-09-30
26.1 K
Advisor Group Holdings, Inc.2024-09-30
21.4 K
Fny Investment Advisers, Llc2024-06-30
18.8 K
State Street Corp2024-09-30
13.8 K
Ubs Group Ag2024-09-30
9.7 K
Tower Research Capital Llc2024-09-30
6.8 K
Bank Of America Corp2024-09-30
41.0

Protagenic Fundamentals

About Protagenic Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Protagenic Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Protagenic Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Protagenic Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Protagenic Stock Analysis

When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.